Paper Title

Selective serotonin reuptake inhibitors (SSRIs) in the treatment of paraphilias

Authors

Profile picture of Peer Briken
Peer Briken
Profile picture of Doz. Dr. med. Andreas Hill
Doz. Dr. med. Andreas Hill
Profile picture of Wolfgang Berner
Wolfgang Berner
Profile picture of phil. Niels C. Habermann
phil. Niels C. Habermann
Profile picture of C Kraus
C Kraus

Keywords

  • Paraphilias
  • Pedophilia
  • Sex Offender
  • SSRI
  • Pharmacotherapy
  • Treatment
  • Paraphilic Symptoms
  • Psychotherapy
  • Sexual Side Effects
  • Male Outpatients
  • Retrospective Study
  • Delinquency
  • "Hands-Off" Delinquency
  • Reduction in Symptoms
  • High Treatment Satisfaction
  • Pharmacological Treatment

Journal

Advances in Neurology Psychiatry External link

Research Impact Tools

DOI

DOI Icon 10.1055/s-2006-944261

Publication Info

Volume: 75 | Issue: 6 | Pages: 351-356

Published On

February, 2007

Downloads

CITATION
COPY LINK

Abstract

For about 15 years selective serotonine reuptake inhibitors (SSRI) have been used in the treatment of paraphilias. In an open, uncontrolled, retrospective study, which was the first in the German speaking countries we investigated 16 male outpatients, who have been treated for different paraphilias with SSRI and psychotherapy. There was a marked reduction in paraphilic symptoms. Despite high rates of sexual side effects most patients reported a high overall treatment satisfaction. SSRI are an important addition in pharmacological treatment of paraphilic patients, especially with a risk of so called “hands-off” delinquency.

View more »